Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum
Open Access
- 1 December 2003
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 87 (6) , 1518-1526
- https://doi.org/10.1046/j.1471-4159.2003.02120.x
Abstract
Activation of glial innate immunity is widely proposed to contribute to a number of degenerative and destructive diseases of brain. However, the precise role of activated innate immunity has been dif...Keywords
This publication has 44 references indexed in Scilit:
- Neuroinflammatory processes in Parkinson's diseaseAnnals of Neurology, 2003
- Microglia and inflammatory mechanisms in the clearance of amyloid β peptideGlia, 2002
- Neuronal oxidative damage from activated innate immunity is EP2 receptor‐dependentJournal of Neurochemistry, 2002
- Protecting the Brain While Killing Pain?Science, 2002
- A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activityNature, 2001
- Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System IschemiaStroke, 2000
- Duration of non-steroidal anti-inflammatory drug use and risk of Alzheimer's disease. The Rotterdam studyNeurobiology of Aging, 2000
- Gene Expression Profile of Aging and Its Retardation by Caloric RestrictionScience, 1999
- Some new, simple and efficient stereological methods and their use in pathological research and diagnosisAPMIS, 1988
- Pattern Discrimination and the Visual CortexNature, 1953